Seroprevalence and associated risk factors of Entamoeba histolytica infection among gastroenteritis patients visited in public healthcare system, Pakistan

Author(s):  
Bisma Khan ◽  
Kiran Afshan ◽  
Sabika Firasat ◽  
Mazhar Qayyum
2020 ◽  
Vol 8 (2) ◽  
pp. 22-35
Author(s):  
Syazwan Saidin ◽  
Adibah Abu Bakar ◽  
Badrul Munir Mohd Zain

Entamoeba infection is still widespread in Malaysia’s rural area particularly among Orang Asli communities which usually associated with poverty and lack of sanitation. Due to scarce information on these Entamoeba infections in Slim River, Perak we conducted this study to investigate the prevalence and associated risk factors towards this infection. A total of 55 stool samples from voluntary participants with and without symptoms of amoebiasis were collected and examined using PCR technique. PCR analysis showed 16.4% stool samples were detected positive for Entamoeba spp., discriminated as 7.3% that were positive for E. histolytica and 9.1% for E. dispar. No E. moshkovskii was detected at all. Factors such as indiscriminate defecation, improper sewage disposal and not washing hand after playing with soil or gardening showed significant association with E. histolytica infection; while gastrointestinal symptom such as vomiting was associated with E. dispar infection. In conclusion, the study reveals there is still an occurrence of Entamoeba spp. among Orang Asli communities in Slim River, Perak. This implies that good personal and hygiene practices should be enhanced through awareness strategy to control Entamoeba infections in Orang Asli communities in Malaysia.


2021 ◽  
Author(s):  
Arlene M. D'Silva ◽  
Hugo Sampaio ◽  
Didu Sanduni Thamarasa Kariyawasam ◽  
David Mowat ◽  
Jacqui Russell ◽  
...  

2017 ◽  
Vol 5 (2) ◽  
pp. 48
Author(s):  
RugaiaMohammed Abdulgader ESalem ◽  
SehamAbobaker Ali Gahgah ◽  
AishaSalih Hamza Ali ◽  
SamahAbdaladhem Rahmma Al Shrief

Bioethica ◽  
2020 ◽  
Vol 6 (2) ◽  
pp. 30
Author(s):  
Nikolaos Kolisis (Νικόλαος Κολίσης)

The invention of CRISPR technology and its current and potential applications have been a subject of controversy among scientists, philosophers and legal theorists. After taking under consideration the current discussion concerning the use of CRISPR for editing human genome the article treats the question of a wider offer of CRISPR-based therapies from a Public Healthcare system and proposes method for a fair and financially sustainable way for adopting the new possibilities this new tool has to offer.


Sign in / Sign up

Export Citation Format

Share Document